Biomarkers of Oxidative Stress in Plasma and Urine

Analytical Techniques for Clinical Chemistry: Methods and Applications

Volumn , Issue , 2012, Pages 555-594

  Subbaiah, Papasani V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Biological systems, mechanisms neutralizing ROS; Degradation products of lipid oxidation; Oxidative stress biomarkers in plasma and urine; Oxidative stress, capacity of body in eliminating ROS; Oxidative stress, markers of oxidative stress, diagnostic and monitoring tools

Indexed keywords

EID: 84879845919     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118271858.ch20     Document Type: Chapter

References (168)

1. Moslen, M. T. (1994) Reactive oxygen species in normal physiology, cell injury and phagocytosis, Adv. Exp. Med. Biol. 366, 17-27.
2. Forman, H. J., Fukuto, J. M., Miller, T., Zhang, H., Rinna, A., and Levy, S. (2008) The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal, Arch. Biochem. Biophys. 477, 183-195.
3. Allen, R. G. and Tresini, M. (2000) Oxidative stress and gene regulation, Free Radical Biol. Med. 28, 463-499.
4. Finkel, T. and Holbrook, N. J. (2000) Oxidants, oxidative stress and the biology of ageing, Nature 408, 239-247.
5. Halliwell, B. and Whiteman, M. (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142, 231-255.
6. Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., and Milzani, A. (2006) Biomarkers of oxidative damage in human disease, Clin. Chem. 52, 601-623.
7. Tsimikas, S. (2006) Measures of oxidative stress, Clin. Lab. Med. 26, 571-590.
8. Dotan,Y., Lichtenberg, D., and Pinchuk, I. (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress, Progr. Lipid Res. 43, 200-227.
9. Magalhaes, L. M., Segundo, M. A., Reis, S., and Lima, J. L. F. C. (2008) Methodological aspects about in vitro evaluation of antioxidant properties, Anal. Chim. Acta 613, 1-19.
10. Tasaka, S., Amaya, F., Hashimoto, S., and Ishizaka, A. (2008) Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome, Antiox. Redox Signal. 10, 739-754.
11. Fukagawa, N. K. (1999) Aging: Is oxidative stress a marker or is it causal? Exp. Biol. Med. 222, 293-298.
12. Samuele De Minicis, D. A. B. (2008) Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex, J. Gastroenterol. Hepatol. 23, S98-S103.
13. Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., and Perry, G. (2000) Oxidative stress in Alzheimer's disease, Biochim. Biophys. Acta 1502, 139-144.
14. Pratico, D., Clark, C. M., Lee, V. M. Y., Trojanowski, J. Q., Rokach, J., and Fitzgerald,-G. A. (2000) Increased 8,12-iso-iPF(2 alpha)-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity, Ann. Neurol. 48, 809-812.
15. Montuschi, P., Corradi, M., Ciabattoni, G., Nightingale, J., Kharitonov, S. A., and Barnes, P. J. (1999) Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients, Am. J. Respir. Crit. Care Med. 160, 216-220.
16. Witztum, J. L. and Steinberg, D. (2001) The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trend Cardiovasc. Med. 11, 93-102.
17. Berliner, J. A., Subbanagounder, G., Leitinger, N., Watson, A. D., and Vora, D. (2001) Evidence for a role of phospholipid oxidation products in atherogenesis, Trend Cardiovasc. Med. 11, 142-147.
18. Halliwell, B. (2007) Oxidative stress and cancer: have we moved forward? Biochem. J. 401, 1-11.
19. Franco, R., Schoneveld, O., Georgakilas, A. G., and Panayiotidis, M. I. (2008) Oxidative stress, DNA methylation and carcinogenesis, Cancer Lett. 266, 6-11.
20. Spector, A. (2000) Review: oxidative stress and disease, J. Ocul. Pharmacol. Ther. 16, 193.
21. Saugstad, O. D. (1998) Chronic lung disease: the role of oxidative stress, Biol. Neonate 74Suppl. 1, 21-28.
22. Barreiro, E., de la, P. B., Minguella, J., Corominas, J. M., Serrano, S., Hussain, S. N., and Gea, J. (2005) Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 171, 1116-1124.
23. Sahin, U., Unlu, M., Ozguner, F., Sutcu, R., Akkaya, A., and Delibas, N. (2001) Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation: prognostic value of malondialdehyde, J. Basic Clin. Physiol. Pharmacol. 12, 59-68.
24. Montuschi, P., Kharitonov, S. A., Ciabattoni, G., Corradi, M., van, R. L., Geddes, D. M., Hodson, M. E., and Barnes, P. J. (2000) Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis, Thorax 55, 205-209.
25. Baynes, J. W. and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications-a new perspective on an old paradigm, Diabetes 48, 1-9: 19.
26. Maritim, R. A. S., Sanders R. A., andWatkins J. B. (2003) Diabetes, oxidative stress, and antioxidants: a review, J. Biochem. Mol. Toxicol. 17, 24-38.
27. Zana, M., Janka, Z., and Kalman, J. (2007) Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease, Neurobiol. Aging 28, 648-676.
28. Beatty, S.,Koh, H. H., Phil, M., Henson, D., and Boulton, M. (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration, Surv. Ophthalmol. 45, 115-134.
29. Sayre, L. M., Perry, G., and Smith, M. A. (2008) Oxidative stress and neurotoxicity, Chem. Res. Toxicol. 21, 172-188.
30. Chalasani, N., Deeg, M. A. and Crabb, D. W. (2004) Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis, Am. J. Gastroenterol. 99, 1497-1502.
31. Keaney, J. F., Jr., Larson, M. G., Vasan, R. S., Wilson, P. W., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., and Benjamin, E. J. (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study, Arterioscler. Thromb. Vasc. Biol. 23, 434-439.
32. Basu, S., Michaelsson, K., Olofsson, H., Johansson, S., and Melhus, H. (2001) Association between oxidative stress and bone mineral density, Biochem. Biophys. Res. Commun. 288, 275-279.
33. Leung, P. S. and Chan, Y. C. (2009) Role of oxidative stress in pancreatic inflammation, Antiox. Redox Signal. 11, 135-166.
34. Drechsel, D. A. and Patel, M. (2008) Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease, Free Radical Biol. Med. 44, 1873-1886.
35. Raijmakers, M. T. M., Dechend, R., and Poston, L. (2004) Oxidative stress and preeclampsia: rationale for antioxidant clinical trials, Hypertension 44, 374-380.
36. Riley, P. A. (1994) Free radicals in biology: oxidative stress and the effects of ionizing radiation, Int. J. Radiat. Biol. 65, 27-33.
37. Shah, S. V., Baliga, R., Rajapurkar, M., and Fonseca, V. A. (2007) Oxidants in chronic kidney disease, J. Am. Soc. Nephrol. 18, 16-28.
38. Hitchon, C. and El-Gabalawy,H. (2004) Oxidation in rheumatoid arthritis, Arthritis Res. Ther. 6, 265-278.
39. Cracowski, J. L., Marpeau, C., Carpentier, P. H., Imbert, B., Hunt, M., Stanke-Labesque, F., and Bessard, G. (2001) Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders, Arthritis Rheum. 44, 1143-1148.
40. Bernhard, D. and Wang, X. L. (2007) Smoking, oxidative stress and cardiovascular diseases-do anti-oxidative therapies fail? Curr. Med. Chem. 14, 1703-1712.
41. Alves, J. D. and Grima, B. (2003) Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis, Current Rheumatology Reports 5, 383-390.
42. Goetz, M. E. and Luch, A. (2008) Reactive species: a cell damaging rout assisting to chemical carcinogens, Cancer Lett. 266, 73-83.
43. Benzie, I. F. F. and Strain, J. J. (1999) Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. In: Lester, P. (Ed.) Methods in Enzymology Oxidants and Antioxidants Part A, Vol. 299, pp. 15-27, Academic Press, New York.
44. Glazer, A. N. (1990) Phycoerythrin fluorescence-based assay for reactive oxygen species, Meth. Enzymol. 186, 161-168.
45. Ghiselli, A., Serafini, M., Natella, F., and Scaccini, C. (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data, Free Radical Biol. Med. 29, 1106-1114.
46. Re, R., Pellegrini, N., Proteggente, A., Pannala, A.,Yang, M., and Rice-Evans, C. (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay, Free Radical Biol. Med. 26, 1231-1237.
47. Winston, G.W.,Regoli, F., Dugas, A. J., Fong, J. H., and Blanchard, K. A. (1998)Arapid gas chromatographic assay for determining oxyradical scavenging capacity of antioxidants and biological fluids, Free Radical Biol. Med. 24, 480-493.
48. Kasai, H., Kawai, K., and Li, Y. s. (2008) Analysis of 8-OH-dG and 8-OH-Gua as biomarkers of oxidative stress, Genes Environ. 30, 33-40.
49. Pilger, A. and Rudiger, H. (2006) 8-Hydroxy-20-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures, Int. Arch. Occup. Environ. Health 80, 1-15.
50. Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A., and Colombo, R. (2003) Protein carbonyl groups as biomarkers of oxidative stress, Clin. Chim. Acta 329, 23-38.
51. Witko-Sarsat, V., Nguyen-Khoa, T., Jungers, P., Drueke, T., and Scamps-Latscha, B. (1999) Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia, Nephrol. Dial. Transplant. 14, 76-78.
52. Niwa, T., Naito, C., Mawjood, A. H., and Imai, K. (2000) Increased glutathionyl hemoglobin in diabetes mellitus and hyperlipidemia demonstrated by liquid chromatography/electrospray ionization-mass spectrometry, Clin. Chem. 46, 82-88.
53. Tsimikas, S. (2008) In vivo markers of oxidative stress and therapeutic interventions, Am. J. Cardiol. 101, S34-S42.
54. Gaut, J. P., Byun, J., Tran, H. D., and Heinecke, J.W. (2002) Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry, Anal. Biochem. 300, 252-259.
55. Chirico, S. (1994) High-performance liquid chromatography-based thiorbarbituric acid tests. In: Methods in Enzymology Oxygen Radicals in Biological Systems Part C, Vol. 233, Academic Press, New York, pp. 314-318.
56. Pilz, J., Meineke, I. and Gleiter, C. H. (2000) Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative, J. Chromatogr. 742, 315-325.
57. Cighetti, G., Debiasi, S., Paroni, R., and Allevi, P. (1999) Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection, Anal. Biochem. 266, 222-229.
58. Yeo, H. C., Liu, J., Helbock, H. J., and Ames, B. N. (1999) Assay of malondialdehyde and other alkanals in biological fluids by gas chromatography-mass spectrometry. In: Lester, P. (Ed.) Methods in Enzymology Oxidants and Antioxidants Part B, Vol. 300, Academic Press, New York, pp. 70-78.
59. Del Rio, D., Stewart, A. J., and Pellegrini, N. (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress, Nutr., Metabol. Cardiovasc. Dis. 15, 316-328.
60. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes, Free Radical Biol. Med. 11, 81-128.
61. Proudfoot, J., Barden, A., Mori, T. A., Burke,V., Croft, K. D., Beilin, L. J., and Puddey, I. (1999) Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation-a comparison of enzyme immunoassay with gas chromatography/mass spectrometry, Anal. Biochem. 272, 209-215.
62. Milne, G. L., Sanchez, S. C., Musiek, E. S., and Morrow, J. D. (2007) Quantification of F2-isoprostanes as a biomarker of oxidative stress, Nat. Protocols 2, 221-226.
63. Sircar, D. and Subbaiah, P. V. (2007) Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation, Clin. Chem. 53, 251-258.
64. Satoh, K., Yamada, S., Koike, Y., Igarashi, Y., Toyokuni, S., Kumano, T., Takahata, T., Hayakari, M., Tsuchida, S., and Uchida, K. (1999) A 1-hour enzymelinked immunosorbent assay for quantitation of acrolein-and hydroxynonenalmodified proteins by epitope-bound casein matrix method, Anal. Biochem. 270, 323-328.
65. Cramer, G. L., Miller, J., Pendleton, R. B., and Lands, W. E. M. (1991) Iodometric measurement of lipid hydroperoxides in human plasma, Anal. Biochem. 193, 204-211.
66. Görög, P., Kotak, D. C., and Kovács, I. B. (1991) Simple and specific test for measuring lipid peroxides in plasma, J. Clin. Pathol. 44, 765-767.
67. Ohshima, T., Hopia, A., German, J. B., and Frankel, E. N. (1996) Determination of hydroperoxides and structures by high-performance liquid chromatography with post-column detection with diphenyl-1-pyrenylphosphine, Lipids 31, 1091-1096.
68. Esterbauer, H., Striegl, G., Puhl, H., and Rotheneder,M. (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein, Free Radical Res. 6, 67-75.
69. McCord, J. M. and Fridovich, I. (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), J. Biol. Chem. 244, 6049-6055.
70. Paglia, D. E. and Valentine, W. N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J. Lab. Clin. Med. 70, 158-169.
71. Johansson, L. H. and Håkan Borg, L. A. (1988) A spectrophotometric method for determination of catalase activity in small tissue samples, Anal. Biochem. 174, 331-336.
72. Yamashita, S. and Yamamoto, Y. (1997) Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress, Anal. Biochem. 250, 66-73.
73. Martin, J. and White, I. N. H. (1991) Fluorimetric determination of oxidised and reduced glutathione in cells and tissues by high-performance liquid chromatography following derivatization with dansyl chloride, J. Chromatog.: Biomed. Appl. 568, 219-225.
74. Theresa DiMarco, C. G. (2007) Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples, Mass Spectrom. Rev. 26, 108-120.
75. Schwemmer, M., Fink, B.,Köckerbauer, R., and Bassenge, E. (2000) Howurine analysis reflects oxidative stress-nitrotyrosine as a potential marker, Clin. Chim. Acta 297, 207-216.
76. Van Hoydonck, P. G., Wuyts, W. A., Vanaudenaerde, B. M., Schouten, E. G., Dupont, L. J., and Temme, E. H. (2004) Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate, Eur. Respir. J. 23, 189-192.
77. Rahman, I. and Biswas, S. K. (2004) Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues, Redox Rep. 9, 125-143.
78. Paredi, P., Kharitonov, S. A., and Barnes, P. J. (2002) Analysis of expired air for oxidation products, Am. J. Respir. Crit. Care Med. 166, S31-S37.
79. Prior,R. L. and Cao, G. (1999) In vivo total antioxidant capacity: comparison of different analytical methods1, Free Radical Biol. Med. 27, 1173-1181.
80. Janaszewska, A. and Bartosz, G. (2002) Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma., Scand. J. Clin. Lab. Invest. 62, 231-236.
81. Wayner, D. D. M., Burton, G. W., Ingold, K. U., and Locke, S. (1985) Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation: the important contribution made by plasma proteins, FEBS Lett. 187, 33-37.
82. Serafini, M., Ghiselli, A., and Ferro-Luzzi, A. (1996) In vivo antioxidant effect of green and black tea in man, Eur. J. Clin. Nutr. 50, 28-32.
83. Serafini, M., Maiani, G., and Ferroluzzi, A. (1998) Alcohol-free red wine enhances plasma antioxidant capacity in humans, J. Nutr. 128, 1003-1007.
84. Ghiselli, A., Serafini, M., Maiani, G., Azzini, E., and Ferro-Luzzi, A. (1995) A fluorescence-based method for measuring total plasma antioxidant capability, Free Radical Biol. Med. 18, 29-36.
85. Ou, B., Hampsch-Woodill, M., and Prior, R. L. (2001) Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe, J. Agric. Food Chem. 49, 4619-4626.
86. Huang, D., Ou, B., Hampsch-Woodill, M., Flanagan, J. A., and Prior, R. L. (2002) Highthroughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format, J. Agric. Food Chem. 50, 4437-4444.
87. Regoli, F. andWinston, G.W. (1999) Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals, Toxicol. Appl. Pharmacol. 156, 96-105.
88. Balercia, G., Armeni, T., Mantero, F., Principato, G., and Regoli, F. (2003) Total oxyradical scavenging capacity toward different reactive oxygen species in seminal plasma and sperm cells, Clin. Chem. Lab. Med. 41, 13-19.
89. Firuzi, O., Lacanna, A., Petrucci, R., Marrosu, G., and Saso, L. (2005) Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry, Biochim. Biophys. Acta 1721, 174-184.
90. Serafini, M. and Del Rio, D. (2004) Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?, Redox Rep. 9, 145-152.
91. Jones, D. P., Carlson, J. L., Samiec, P. S., Sternberg, P., Mody, V. C., Reed, R. L., and Brown, L. A. (1998) Glutathione measurement in human plasma: evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC, Clin. Chim. Acta 275, 175-184.
92. Svardal, A. R. M., Mansoor, M. A., and Ueland, P. M. (1990) Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography, Anal. Biochem. 184, 338-346.
93. Lim, H. H. T. (2006) Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q10 Diab. Med. 23, 1344-1349.
94. Lagendijk, J., Ubbink, J. B., Delport, R., Vermaak, W. J., and Human, J. A. (1997) Ubiquinol/ubiquinone ratio as marker of oxidative stress in coronary artery disease, Res. Commun. Mol. Pathol. Pharmacol. 95, 11-20.
95. Finckh, B., Kontush, A., Commentz, J., Hnbner, C., Burdelski, M., and Kohlschntter, A. (1995) Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection, Anal. Biochem. 232, 210-216.
96. Mosca, F., Fattorini, D., Bompadre, S., and Littarru, G. P. (2002) Assay of coenzyme Q10 in plasma by a single dilution step, Anal. Biochem. 305, 49-54.
97. Dukan, S., Farewell, A., Ballesteros, M., Taddei, F., Radman, M., and Nystrom,T. (2000) Protein oxidation in response to increased transcriptional or translational errors, Proc. Natl. Acad. Sci. U.S.A 97, 5746-5749.
98. Buss, I. H. and Winterbourn, C. C. (2002) Protein carbonyl measurement by ELISA, Meth. Mol. Biol. 186, 123-128.
99. Winterbourn, C. C., Bonham, M. J. D., Buss, H., bu-Zidan, F. M., and Windsor, J. A. (2003) Elevated protein carbonyls as plasma markers of oxidative stress in acute pancreatitis, Pancreatology 3, 375-382.
100. Trombetta, D., Gangemi, S., Saija, A., Minciullo, P. L., Cimino, F., Cristani, M., Briuglia, S., Piraino, B., Isola, S., and Salpietro, C. D. (2006) Increased protein carbonyl groups in the serum of patients affected by thalassemia major, Ann. Hematol. 85, 520-522.
101. Oettl, K., Stadlbauer, V., Petter, F., Greilberger, J., Putz-Bankuti, C., Hallström, S., Lackner, C., and Stauber, R. E. (2008) Oxidative damage of albumin in advanced liver disease, Biochim. Biophys. Acta 1782, 469-473.
102. Scamps-Latscha, B. and Witko-Sarsat, V. (2001) Importance of oxidatively modified proteins in chronic renal failure, Kidney Int. Suppl. 59, S108-S113.
103. Rabbani, N. and Thornalley, P. J. (2008) Assay of 3-nitrotyrosine in tissues and body fluids by liquid chromatography with tandem mass spectrometric detection, Methods Enzymol. 440, 337-359.
104. Uchida, K. (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress, Prog. Lipid Res. 42, 318-343.
105. Dizdaroglu, M., Jaruga, P., Birincioglu, M., and Rodriguez, H. (2002) Free radicalinduced damage to DNA: mechanisms and measurement, Free Radic. Biol. Med. 32, 1102-1115.
106. Ravanat, J. L., Turesky, R. J., Gremaud, E., Trudel, L. J., and Stadler, R. H. (1995) Determination of 8-oxoguanine in DNA by gas chromatography-mass spectrometry and HPLC-electrochemical detection: overestimation of the background level of the oxidized base by the gas chromatography-mass spectrometry assay, Chem. Res. Toxicol. 8, 1039-1045.
107. Yin, B., Whyatt, R. M., Perera, F. P., Randall, M. C., Cooper, T. B., and Santella, R. M. (1995) Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA, Free Radical Biol. Med. 18, 1023-1032.
108. Collins, A. R., Cadet, J., Moller, L., Poulsen, H. E., and Vina, J. (2004) Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch. Biochem. Biophys. 423, 57-65.
109. Collins, A. R., Dobson, V. L., Duinská, M., Kennedy, G., and Stêtina, R. (1997) The comet assay: what can it really tell us? Mutat. Res. 375, 183-193.
110. Dobarganes, M. C. andVelasco, J. (2002) Analysis of lipid hydroperoxides, Eur. J. Lipid Sci. Technol. 104, 420-428.
111. Roberts, L. J. I., Fessel, J. P., and Davies, S. S. (2005) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol. 15, 143-148.
112. Frei, B., Yamamoto, Y., Niclas, D., and Ames, B. N. (1988) Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma, Anal. Biochem. 175, 120-130.
113. Situnayake, R. D., Crump, B. J., Zezulka, A. V., Davis, M., McConkey, B., and Thurnham, D. I. (1990) Measurement of conjugated diene lipids by derivative spectroscopy in heptane extracts of plasma, Ann. Clin. Biochem. 27, 258-266.
114. Gebicki, J. M. and Guille, J. (1989) Spectrophotometric and high-performance chromatographic assays of hydroperoxides by the iodometric technique, Anal. Biochem. 176, 360-364.
115. Pastorino, A. M., Maiorino, M., and Ursini, F. (2000) Kinetic analysis of lipidhydroperoxides in plasma, Free Radical Biol. Med. 29, 397-402.
116. Walter,M. F., Jacob, R. F., Bjork, R. E., Jeffers, B., Buch, J., Mizuno,Y., and Mason, R. P. (2008) Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study, J. Am. Coll. Cardiol. 51, 1196-1202.
117. Miyazawa, T. (1989) Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay, Free Radicals B. 7, 209-217.
118. Steghens, J. P., van Kappel, A. L., Denis, I., and Collombel, C. (2001) Diaminonaphtalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum, Free Radical Biol. Med. 31, 242-249.
119. Rauli, S., Puppo, M. D., Magni, F., and Kienle, M. G. (1998) Validation of malondialdehyde and 4-hydroxy-2-trans-nonenal measurement in plasma by NICI-GC-MS, J. Biochem. (Tokyo). 123, 918-923.
120. Ayyobi, A. F., McGladdery, S. H., Chan, S., John Mancini, G. B., Hill, J. S., and Frohlich, J. J. (2004) Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up, Atherosclerosis 177, 361-366.
121. Kadiiska, M. B., Gladen, B. C., Baird, D. D., Germolec, D., Graham, L. B., Parker, C. E., Nyska, A., Wachsman, J. T., Ames, B. N., Basu, S., Brot, N., Fitzgerald, G. A., Floyd, R. A., George, M., Heinecke, J. W., Hatch, G. E., Hensley, K., Lawson, J. A., Marnett, L. J., Morrow, J. D., Murray, D. M., Plastaras, J., Roberts, L. J., II, Rokach, J., Shigenaga, M. K., Sohal, R. S., Sun, J., Tice, R. R., Van Thiel, D. H., Wellner, D., Walter, P. B., Tomer, K. B., Mason, R. P., and Barrett, J. C. (2005) Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?, Free Radical Biol. Med. 38, 698-710.
122. Poli, G., Schaur, R. J., Siems, W. G., and Leonarduzzi, G. (2008) 4-Hydroxynonenal: A membrane lipid oxidation product of medicinal interest, Med. Res. Rev. 28, 569-631.
123. Blair, I. A., Lawson, J. A., Ischiropoulos, H., and FitzGerald, G. A. (2006) Biomarkers of oxidant stress in vivo: oxidative modifications of lipids, proteins and DNA. In: Developments in Cardiovascular Medicine. Antioxidants and Cardiovascular Disease 2nd ed., Springer Link, Berlin, pp. 131-165.
124. Aghdassi, E. and Allard, J. P. (2000) Breath alkanes as a marker of oxidative stress in different clinical conditions, Free Radical Biol. Med. 28, 880-886.
125. Kanoh, S., Kobayashi, H., and Motoyoshi, K. (2005) Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases, Chest 128, 2387-2392.
126. Cope, K. A., Solga, S. F., Hummers, L. K.,Wigley, F. M., Diehl, A. M., and Risby, T. H. (2006) Abnormal exhaled ethane concentrations in scleroderma, Biomarkers 11, 70-84.
127. Phillips, M., Cataneo, R. N., Cheema, T., and Greenberg, J. (2004) Increased breath biomarkers of oxidative stress in diabetes mellitus, Clin. Chim. Acta 344, 189-194.
128. Phillips, M., Cataneo, R. N. M., Greenberg, J. B., Grodman, R. M., and Salazar, M. M. (2003) Breath markers of oxidative stress in patients with unstable angina., Heart Disease 5, 95-99.
129. Borrill, Z. L., Roy, K., and Singh, D. (2008) Exhaled breath condensate biomarkers in COPD, Eur. Respir. J. 32, 472-486.
130. von Basum, G., Dahnke, H., Halmer, D., Hering, P., and Murtz, M. (2003) Online recording of ethane traces in human breath via infrared laser spectroscopy, J. Appl. Physiol. 95, 2583-2590.
131. Montuschi, P., Barnes, P. J., and Roberts, L. J. (2004) Isoprostanes: markers and mediators of oxidative stress, FASEB J. 18, 1791-1800.
132. Lawson, J. A., Rokach, J., and Fitzgerald, G. A. (1999) Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo, J. Biol. Chem. 274, 24441-24444.
133. Cracowski, J. L., Durand, T., and Bessard, G. (2002) Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications, Trends Pharmacol. Sci. 23, 360-366.
134. Morrow, J. D. (2006) The isoprostanes-Unique products of arachidonate peroxidation: Their role as mediators of oxidant stress, Curr. Pharm. Des. 12, 895-902.
135. Davies, S. S., Zackert,W., Luo,Y., Cunningham, C. C., Frisard, M., and Roberts, L. J. II. (2006) Quantification of dinor-dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry, Anal. Biochem. 348, 185-191.
136. Tsikas, D., Schwedhelm, E., Suchy,M. T., Niemann, J., Gutzki, F. M., Erpenbeck, V. J., Hohlfeld, J. M., Surdacki, A., and Frolich, J. C. (2003) Divergence in urinary 8-iso-PGF2α (iPF2α-III, 15-F2t-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF2a: possible methodological, mechanistic and clinical implications, J. Chromatogr. 794, 237-255.
137. Il'yasova, D., Morrow, J. D., Ivanova, A., and Wagenknecht, L. E. (2004) Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane, Ann. Epidemiol. 14, 793-797.
138. Signorini, C., Perrone, S., Sgherri, C., Ciccoli, L., Buonocore, G., Leoncini, S., Rossi,V., Vecchio, D., and Comporti, M. (2008) Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of non protein-bound iron. Ped. Res. 63 287-291.
139. 2-isoprostanes following intravenous iron infusion in patients on hemodialysis, Kidney Int. 60, 1525-1531.
140. Ohashi, N. and Yoshikawa, M. (2000) Rapid and sensitive quantification of 8-isoprostaglandin F2[alpha] in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry, J. Chromatogr. 746, 17-24.
141. Li, H., Lawson, J. A., Reilly, M., Adiyaman, M., Hwang, S. W., Rokach, J., and FitzGerald, G. A. (1999) Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F2 in human urine, Proc. Natl. Acad. Sci. U.S.A. 96, 13381-13386.
142. Coolen, S. A. J., van Buuren, B., Duchateau, G., Upritchard, J., and Verhagen, H. (2005) Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma, Amino Acids 29, 429-436.
143. Carmella, S. G., Chen, M., Zhang, Y., Zhang, S., Hatsukami, D. K., and Hecht, S. S. (2007) Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking, Chem. Res. Toxicol. 20, 986-990.
144. Steinberg, D. (1997) A critical look at the evidence for the oxidation of LDL in atherogenesis, Atherosclerosis 131 (Suppl): S5-S7.
145. Hulthe, J. and Fagerberg, B. (2002) Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study), Arterioscler. Thromb. Vasc. Biol. 22, 1162-1167.
146. Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., and Van de Werf, F. (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease, Arterioscler. Thromb. Vasc. Biol. 21, 844-848.
147. Holvoet, P., Kritchevsky, S. B., Tracy, R. P., Mertens, A., Rubin, S. M., Butler, J., Goodpaster, B., and Harris, T. B. (2004) The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort, Diabetes 53, 1068-1073.
148. Kato, R., Mori, C., Kitazato, K., Arata, S., Obama, T., Mori, M., Takahashi, K., Aiuchi, T., Takano, T., and Itabe, H. (2009) Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice, Arterioscler. Thromb. Vasc. Biol. 29, 33-39.
149. Holvoet, P., Donck, J., Landeloos, M., Brouwers, E., Luijtens, K., Arnout, J., Lesaffre,-E., Vanrenterghem, Y., and Collen, D. (1996) Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure, Thromb. Haemost. 76 663-669.
150. Itabe, H., Yamamoto, H., Imanaka, T., Shimamura, K., Uchiyama, H., Kimura, J., Sanaka, T., Hata, Y., and Takano, T. (1996) Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody, J. Lipid Res. 37, 45-53.
151. Palinski,W., Horkko, S., Miller, E., Steinbrecher,U. P., Powell, H. C., Curtiss, L. K., and Witztum, J. L. (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice-demonstration of epitopes of oxidized low density lipoprotein in human plasma, J. Clin. Invest. 98, 800-814.
152. van der Zwan, L. P., Teerlink, T., Dekker, J. M., Henry, R. M. A., Stehouwer, C. D. A., Jakobs, C., Heine, R. J., and Scheffer, P. G. (2009) Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation, J. Lipid Res. 50, 342-349.
153. Itabe, H. and Ueda, M. (2007) Measurement of plasma oxidized low-density lipoprotein and its clinical implications, J. Atheroscler. Thromb. 14, 1-11.
154. Mcdowell, I. F. W., McEneny, J., and Trimble, E. R. (1995) A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein, Ann. Clin. Biochem. 32, 167-174.
155. Gieseg, S. P. and Esterbauer, H. (1994) Low density lipoprotein is saturable by prooxidant copper, FEBS Lett. 343, 188-194.
156. Hussein, O. A., Gefen, Y., Zidan, J. M., Karochero, E. Y., Luder, A. S., Assy, N. N., Sror, E. S., and Aviram, M. Y. (2007) LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients, Clin. Chim. Acta 377, 114-118.
157. Napoli, C., Postiglione, A., Triggiani, M., Corso, G., Palumbo, G., Carbone, V., Ruocco, A., Ambrosio, G., Montefusco, S., Malorni, A., Condorelli, M., and Chiariello, M. (1995) Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia, Atherosclerosis 118, 259-273.
158. Hendrickson, A., McKinstry, L. A., Lewis, J. K., Lum, J., Louie, A., Schellenberg, G. D., Hatsukami, T. S., Chait, A., and Jarvik, G. P. (2005) Ex vivo measures of LDL oxidative susceptibility predict carotid artery disease, Atherosclerosis 179, 147-153.
159. Nicholls, S. J. and Hazen, S. L. (2005) Myeloperoxidase and cardiovascular disease, Arterioscler. Thromb. Vasc. Biol. 25, 1102-1111.
160. Brennan, M. L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor,M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., Nissen, S. E., and Hazen, S. L. (2003) Prognostic value of myeloperoxidase in patients with chest pain, N. Engl. J. Med. 349, 1595-1604.
161. Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Munzel, T., Simoons, M. L., Hamm, C. W., and on behalf of the CAPTURE Investigators (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes, Circulation 108, 1440-1445.
162. Vita, J. A., Brennan, M. L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor,M. H., Penn, M. S., Keaney, J. F., Jr., and Hazen, S. L. (2004) Serum myeloperoxidase levels independently predict endothelial dysfunction in humans, Circulation 110, 1134-1139.
163. Stefanescu, A., Braun, S., Ndrepepa, G., Koppara, T., Pavaci, H., Mehilli, J., Schömig, A., and Kastrati, A. (2008) Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease, Am. Heart J. 155, 356-360.
164. Gandley, R. E., Rohland, J., Zhou, Y., Shibata, E., Harger, G. F., Rajakumar, A., Kagan, V. E., Markovic, N., and Hubel, C. A. (2008) Increased myeloperoxidase in the placenta and circulation of women with preeclampsia, Hypertension 52, 387-393.
165. Zachara, B. A., Gromadzinska, J., Wasowicz, W., and Zbrog, Z. (2006) Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review, Acta Biochim. Pol. 53, 663-677.
166. Lubos, E., Loscalzo, J., and Handy, D. E. (2007) Homocysteine and glutathione peroxidase-1, Antioxid. Redox Signal. 9, 1923-1940.
167. Heinecke, J.W. (2006) Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?, J. Exp. Med. 203, 813-816.
168. Witztum, J. L. and Steinberg, D. (2001) The oxidative modification hypothesis of atherosclerosis: does it hold for humans?, Trends. Cardiovasc. Med. 11, 93-102.